
Koninklijke DSM N.V. – OTC:RDSMY
Koninklijke DSM N.V. stock price today
Koninklijke DSM N.V. stock price monthly change
Koninklijke DSM N.V. stock price quarterly change
Koninklijke DSM N.V. key metrics
Market Cap | 23.41B |
Enterprise value | N/A |
P/E | 28.79 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 2.30 |
PEG ratio | -0.63 |
EPS | 0.77 |
Revenue | 8.57B |
EBITDA | 651M |
Income | 534M |
Revenue Q/Q | -3.34% |
Revenue Y/Y | -4.85% |
Profit margin | 8.12% |
Oper. margin | 21.23% |
Gross margin | 34.38% |
EBIT margin | 21.23% |
EBITDA margin | 7.59% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeKoninklijke DSM N.V. stock price history
Koninklijke DSM N.V. stock forecast
Koninklijke DSM N.V. financial statements
Mar 2020 | 2.29B | 167M | 7.28% |
---|---|---|---|
Jun 2020 | 2.23B | 101M | 4.51% |
Sep 2020 | 1.96B | 167M | 8.52% |
Dec 2020 | 2.08B | 99M | 4.76% |
Payout ratio | 35.61% |
---|
2017 | 0.61% |
---|---|
2018 | 0.66% |
2019 | 0.83% |
2020 | 0.92% |
2021 | 0.79% |
Dec 2020 | 14364000000 | 6.87B | 47.88% |
---|---|---|---|
Jun 2021 | 15095000000 | 6.5B | 43.06% |
Dec 2021 | 16013000000 | 6.61B | 41.32% |
Jun 2022 | 16853000000 | 7.03B | 41.71% |
Mar 2020 | 287M | 326M | -12M |
---|---|---|---|
Jun 2020 | 297M | -1.31B | 932M |
Sep 2020 | 406M | 502M | -517M |
Dec 2020 | 504M | -996M | -320M |
Koninklijke DSM N.V. alternative data
Aug 2023 | 21,760 |
---|---|
Sep 2023 | 21,760 |
Oct 2023 | 21,760 |
Nov 2023 | 21,760 |
Dec 2023 | 21,760 |
Jan 2024 | 21,760 |
Feb 2024 | 21,760 |
Mar 2024 | 21,760 |
Apr 2024 | 21,760 |
May 2024 | 21,760 |
Jun 2024 | 21,760 |
Jul 2024 | 21,760 |
Koninklijke DSM N.V. other data
Quarter | Transcript |
---|---|
Q2 2022 2 Aug 2022 | Q2 2022 Earnings Call Transcript |
Q4 2020 16 Feb 2021 | Q4 2020 Earnings Call Transcript |
-
What's the price of Koninklijke DSM N.V. stock today?
One share of Koninklijke DSM N.V. stock can currently be purchased for approximately $32.77.
-
When is Koninklijke DSM N.V.'s next earnings date?
Unfortunately, Koninklijke DSM N.V.'s (RDSMY) next earnings date is currently unknown.
-
Does Koninklijke DSM N.V. pay dividends?
No, Koninklijke DSM N.V. does not pay dividends.
-
How much money does Koninklijke DSM N.V. make?
Koninklijke DSM N.V. has a market capitalization of 23.41B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13.55% to 9.2B US dollars.
-
What is Koninklijke DSM N.V.'s stock symbol?
Koninklijke DSM N.V. is traded on the OTC under the ticker symbol "RDSMY".
-
What is Koninklijke DSM N.V.'s primary industry?
Company operates in the Basic Materials sector and Specialty Chemicals industry.
-
How do i buy shares of Koninklijke DSM N.V.?
Shares of Koninklijke DSM N.V. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Koninklijke DSM N.V. have?
As Jul 2024, Koninklijke DSM N.V. employs 21,760 workers.
-
When Koninklijke DSM N.V. went public?
Koninklijke DSM N.V. is publicly traded company for more then 24 years since IPO on 16 Jul 2001.
-
What is Koninklijke DSM N.V.'s official website?
The official website for Koninklijke DSM N.V. is dsm.com.
Koninklijke DSM N.V. company profile:

Koninklijke DSM N.V.
dsm.comOTC
21,760
Specialty Chemicals
Basic Materials
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Heerlen, 6411 TE
:
ISIN: US7802491081
CUSIP: 23332H202